Delivery Order SPE2DB22D3501-SPE2DB26FTH05
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Oxycodone HCL 5 mg/5 mL unit dose cups (5 mL volume) with a ceiling value of $1,883.02. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,283.47 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Oxycodone HCL 5 mg/5 mL in unit dose cups (5 mL). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical transaction supporting federal medical supply requirements, with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Oxycodone HCL 5 mg/5 ml unit dose cups at a ceiling value of $2,651.94. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a $1,178.48 delivery order to AmerisourceBergen Drug Corp for the supply of Oxycodone HCL 5 mg/5 ml cup unit dose 5 ml on October 14, 2025, with an ultimate completion date of October 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger vehicle supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,548.75 to AmerisourceBergen Drug Corp for the supply of Oxycodone HCL 5 mg/5 mL unit dose cups on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a pharmaceutical supply requirement fulfilled through competitive procurement. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,475.74 to AmerisourceBergen Drug Corp for the supply of Oxycodone HCL 5 mg/5 ml in unit dose cups (5 ml) with an ultimate completion date of April 25, 2025. This firm fixed price, non-set-aside contract was competitively awarded to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Oxycodone HCL 5 mg/5 ml in unit dose cups (5 ml) with a ceiling value of $2,203.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to complete by June 2, 2025, and performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Oxycodone HCL (IR) 5 mg tablets in quantities of 500 units at a firm fixed price of $1,135.41. The contract, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,175.05 to AmerisourceBergen Drug Corp for the supply of Oxycodone HCL 5 mg/5 mL cup unit dose (5 mL containers). The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Oxycodone-Acetaminophen 5-325 mg unit dose packages in quantities of 100. This competitive, non-set-aside delivery order carries a ceiling value of $1,313.14 and is scheduled for completion by October 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH05Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Oxycodone HCL 5 mg/5 mL in unit dose cups (5 mL each) with a ceiling value of $1,314.55. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill medical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for controlled pharmaceutical products represents routine fulfillment of the contractor's obligations under the broader DLA Medical Supply Chain framework, which strategically ensures reliable access to essential medications for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/29/25 |